Abstract:There is increasing interest in changing the emphasis of tumor classification from morphologic to molecular. Gene expression profiles may offer more information than morphology and provide an alternative to morphology-based tumor classification systems. Gene selection involves a search for gene subsets that are able to discriminate tumor tissue from normal tissue, and may have either clear biological interpretation or some implication in the molecular mechanism of the tumorigenesis. Gene selection is a fundamental issue in gene expression-based tumor classification. In the formation of a discriminant rule, the number of genes is large relative to the number of tissue samples. Too many genes can harm the performance of the tumor classification system and increase the cost as well. In this report, we discuss criteria and illustrate techniques for reducing the number of genes and selecting an optimal (or near optimal) subset of genes from an initial set of genes for tumor classification. The practical advantages of gene selection over other methods of reducing the dimensionality (e.g., principal components), include its simplicity, future cost savings, and higher likelihood of being adopted in a clinical setting. We analyze the expression profiles of 2000 genes in 22 normal and 40 colon tumor tissues, 5776 sequences in 14 human mammary epithelial cells and 13 breast tumors, and 6817 genes in 47 acute lymphoblastic leukemia and 25 acute myeloid leukemia samples. Through these three examples, we show that using 2 or 3 genes can achieve more than 90% accuracy of classification. This result implies that after initial investigation of tumor classification using microarrays, a small number of selected genes may be used as biomarkers for tumor classification, or may have some relevance in tumor development and serve as a potential drug target. In this report we also show that stepwise Fisher's linear discriminant function is a practicable method for gene expression-based tumor classification.

Generalized Discriminant Analysis for Tumor Classification with Gene Expression Data

Independent Component Analysis-Based Penalized Discriminant Method for Tumor Classification Using Gene Expression Data.

RPCA-Based Tumor Classification Using Gene Expression Data

Penalized independent component discriminant method for tumor classification

Independent component analysis-based penalized discriminant method for tumor classification using gene expression data

Computational Methods for Gene Expression-Based Tumor Classification

Research of a Tumor Diagnosis Algorithm Based on Principal Component Analysis

Using 2d principal component analysis to reduce dimensionality of gene expression profiles for tumor classification

A Dynamic Subspace Learning Method for Tumor Classification Using Microarray Gene Expression Data

Molecular Diagnosis of Tumor Based on Independent Component Analysis and Support Vector Machines

Tumor Classification Based on Independent Component Analysis

Partial Least Squares Based Dimension Reduction with Gene Selection for Tumor Classification

Informative gene selection and tumor classification by null space LDA for microarray data

A Robust Hybrid Approach Based on Estimation of Distribution Algorithm and Support Vector Machine for Hunting Candidate Disease Genes.

Cancer classification based on microarray gene expression data using a principal component accumulation method

Dimension reduction with redundant gene elimination for tumor classification

Locally Linear Discriminant Embedding for Tumor Classification

Multi-Class Cancer Classification by Total Principal Component Regression (tpcr) Using Microarray Gene Expression Data

Feature (gene) Selection in Gene Expression-Based Tumor Classification

Discriminant Projection Shared Dictionary Learning for Classification of Tumors Using Gene Expression Data.

Using fuzzy kernel discriminant analysis for tumor classification with gene expression data